Unknown

Dataset Information

0

Development of Triptolide Self-Microemulsifying Drug Delivery System and Its Anti-tumor Effect on Gastric Cancer Xenografts.


ABSTRACT: Purpose: To develop a triptolide (TP) self-microemulsifying drug delivery system and to investigate its anti-tumor effect on human gastric cancer line MGC80-3 xenografts in nude mice. Methods: The medium chain triglyceride (MCT) was selected as oil phase; polyoxyethylene castor oil (EL) was selected as surfactant, and PEG-400 was selected as cosurfactant. The mass ratio of each phase was optimized by central composite design and response surface methodology to prepare TP-SMEDDS (self-microemulsifying drug delivery system). The quality of TP-SMEDDS was evaluated, and its inhibitory effect on tumor growth investigated in nude mice transplanted with MGC80-3 cells. Results: The final prescription process was defined as follows: MCT mass ratio: 25.3%; EL mass ratio: 49.6%; PEG-400 mass ratio: 25.1%. The prepared TP-SMEDDS was a transparent liquid with a clear appearance (the theoretical particle size: 31.168 nm). On transmission electron microscopy, the microemulsion particles were spherical in size and uniformly distributed without adhesions. The in vitro release experiment showed complete release of the prepared TP-SMEDDS in PBS solution in 6 h. In vivo antitumor activity showed its inhibitory effect in the xenograft model. Conclusion: The self-microemulsifying delivery system improved the oral bioavailability and the in vivo antitumor effect of TP.

SUBMITTER: Xie M 

PROVIDER: S-EPMC6788343 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Development of Triptolide Self-Microemulsifying Drug Delivery System and Its Anti-tumor Effect on Gastric Cancer Xenografts.

Xie Minghua M   Wu Jia J   Ji Liqaing L   Jiang Xiaorui X   Zhang Jin J   Ge Min M   Cai Xinjun X  

Frontiers in oncology 20191003


<b>Purpose:</b> To develop a triptolide (TP) self-microemulsifying drug delivery system and to investigate its anti-tumor effect on human gastric cancer line MGC80-3 xenografts in nude mice. <b>Methods:</b> The medium chain triglyceride (MCT) was selected as oil phase; polyoxyethylene castor oil (EL) was selected as surfactant, and PEG-400 was selected as cosurfactant. The mass ratio of each phase was optimized by central composite design and response surface methodology to prepare TP-SMEDDS (se  ...[more]

Similar Datasets

| S-EPMC7076376 | biostudies-literature
| S-EPMC5708845 | biostudies-literature
| S-EPMC10747691 | biostudies-literature
| S-EPMC4463677 | biostudies-literature
| S-EPMC6281252 | biostudies-literature
| S-EPMC10459739 | biostudies-literature
| S-EPMC2882528 | biostudies-literature
| S-EPMC6391151 | biostudies-other
| S-EPMC7357111 | biostudies-literature
| S-EPMC10470285 | biostudies-literature